An observational prospective cohort study for long-term management of hyperkalemia in patients with chronic kidney disease or heart failure - HK registry

Study identifier:D9480R00027

ClinicalTrials.gov identifier:NCT05297409

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

Hyperkalemia registry An observational prospective cohort study for long-term management of hyperkalemia in patients with chronic kidney disease or heart failure

Medical condition

Hyperkalemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

352

Study type

Observational

Age

20 Years - n/a

Date

Study Start Date: 21 May 2022
Estimated Primary Completion Date: 08 Aug 2025
Estimated Study Completion Date: 08 Aug 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria